Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Archives of Internal Medicine

• Publication date

  2009-04-27

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1001/archinternmed.2009.39PMID 19398686PMCID PMC2681242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiepileptic Drugs in Non-Epilepsy Disorders

  2012cited by this paper
• Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change.

  2008cited by this paper
• Medicare Part D prescription drug benefits and administrative burden in the care of dually eligible psychiatric patients.

  2008cited by this paper
• Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.

  2008cited by this paper
• Coverage and prior authorization of psychotropic drugs under Medicare Part D.

  2007cited by this paper
• The CATIE Schizophrenia Trial: Results, Impact, Controversy

  2007cited by this paper
• Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.

  2007cited by this paper
• Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis.

  2007cited by this paper
• Medicaid policies to contain psychiatric drug costs.

  2005cited by this paper
• Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder

  2005cited by this paper
• Benefits and consequences for the poor and the disabled.

  2005cited by this paper
• Segmented regression analysis of interrupted time series studies in medication use research

  2002cited by this paper
• Effects of restrictive formularies in the ambulatory care setting.

  2002cited by this paper
• A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder.

  2002cited by this paper
• Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

  2001cited by this paper
• SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.

  1999cited by this paper
• Effect of mental health specialty care on antidepressant length of therapy.

  1999cited by this paper
• The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

  1998cited by this paper
• Analysis of longitudinal data

  1998cited by this paper
• Cost-effectiveness of antidepressant medications.

  1998cited by this paper
• Survival Analysis Using SAS: A Practical Guide, Second Edition

  1995cited by this paper
• Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

  1987cited by this paper
• Payment Restrictions for Prescription Drugs under Medicaid

  1987cited by this paper
• Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care.

  1981cited by this paper

• Pharmacoepidemiological Approaches in Health Care

  2020cites this paper
• Pharmacy Practice Research Methods

  2020cites this paper
• A Survey of American Psychiatrists Concerning Medication Prior Authorization Requirements.

  2020cites this paper
• Medication prior authorization from the providers perspective: A prospective observational study.

  2019cites this paper
• Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis

  2018cites this paper
• Coverage of Medications That Treat Opioid Use Disorder and Opioids for Pain Management in Marketplace Plans, 2017

  2018cites this paper
• Impact of bundled payments on hip fracture outcomes: a nationwide population-based study

  2018cites this paper
• The Effect of Formulary Restrictions on Patient and Payer Outcomes: A Systematic Literature Review.

  2017cites this paper
• Goals of care conversation teaching in residency – a cross-sectional survey of postgraduate program directors

  2017cites this paper
• Fostering Psychotropic Medication Oversight for Children in Foster Care: A National Examination of States’ Monitoring Mechanisms

  2017cites this paper
• The Impact of the Massachusetts Behavioral Health Child Screening Policy on Service Utilization.

  2017cites this paper
• A mixed methods evaluation of health system responsiveness to FDA psychotropic medication warnings

  2017cites this paper
• Prior authorization policies in Medicaid programs: The importance of study design and analysis on findings and outcomes from research.

  2016cites this paper
• Effects of eliminating drug caps on racial differences in antidepressant use among dual enrollees with diabetes and depression.

  2015cites this paper
• Psychosocial Interventions for Mental and Substance Use Disorders: A Framework for Establishing Evidence-Based Standards

  2015cites this paper
• Urban-Rural Differences in Oral Bisphosphonate Utilization in Ontario Following Formulary Changes and Introduction of New Formulations

  2015cites this paper
• Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations.

  2015cites this paper
• Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene Inhibitors.

  2015cites this paper
• The Effects of Prior Authorization Policies on Medicaid-Enrolled Children's Use of Antipsychotic Medications: Evidence from Two Mid-Atlantic States

  2014cites this paper
• Impact of a Prior Authorization Policy for Montelukast on Clinical Outcomes for Asthma and Allergic Rhinitis Among Children and Adolescents in a State Medicaid Program

  2014cites this paper
• Changes in Use of Lipid-lowering Medications Among Black and White Dual Enrollees With Diabetes Transitioning From Medicaid to Medicare Part D Drug Coverage

  2014cites this paper
• A Systematic Literature Review Assessing the Directional Impact of Managed Care Formulary Restrictions on Medication Adherence, Clinical Outcomes, Economic Outcomes, and Health Care Resource Utilization

  2014cites this paper
• Can major systematic reviews influence practice patterns? A case study of episiotomy trends

  2013cites this paper
• Impact of access restrictions on varenicline utilization

  2013cites this paper
• Use of interrupted time series analysis in evaluating health care quality improvements.

  2013cites this paper
• Use of administrative data to identify off-label use of second-generation antipsychotics in a Medicaid population.

  2013cites this paper
• Dalfampridine Prior Authorization Program: A Cohort Study

  2013cites this paper
• Examination of Why Some Community Pharmacists Do Not Provide 72-Hour Emergency Prescription Drugs to Medicaid Patients When Prior Authorization Is Not Available

  2013cites this paper
• UseofAdministrativeDatatoIdentify Off-LabelUseofSecond-Generation AntipsychoticsinaMedicaidPopulation

  2013cites this paper
• Rosiglitazone Prior Authorization Safety Policy: A Cohort Study

  2012cites this paper
• PHP13 Impact of Medicare Part D on Pharmaceutical and Medical Utilization in Arizona's Dual Eligible Population

  2012cites this paper
• Original article Evolutionary cost analysis of valsartan initiation among patients with hypertension: a time series approach

  2012cites this paper
• An analysis of the slowdown in growth of spending for psychiatric drugs, 1986-2008.

  2012cites this paper
• Uusien lääkkeiden markkinoille tulo ja lääkekustannuksiin vaikuttaminen

  2012cites this paper
• Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder.

  2012cites this paper
• The financial burden from prescription drugs has declined recently for the nonelderly, although it is still high for many.

  2012cites this paper
• Nonelderly , Although It Is Still High For Many The Financial Burden From Prescription Drugs Has Declined Recently For The Banthin

  2012cites this paper
• Evolutionary cost analysis of valsartan initiation among patients with hypertension: a time series approach

  2012cites this paper
• Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study.

  2011cites this paper
• Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder.

  2011cites this paper
• Association Between Prior Authorization for Psychiatric Medications and Use of Health Services Among Medicaid Patients With Bipolar Disorder

  2011cites this paper
• Effect of 6 managed care pharmacy tools: a review of the literature.

  2010cites this paper
• Effect of 6 Managed Care Pharmacy Tools: A Review of the Literature

  2010cites this paper
• Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study.

  2010cites this paper
• Unintended Impacts of a Medicaid Prior Authorization Policy on Access to Medications for Bipolar Illness

  2010influential citation
• The change we need in health care.

  2009cites this paper
• Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting.

  2009cites this paper
• Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D.

  2009cites this paper
• Current awareness in human psychopharmacology

  2009cites this paper
• Evaluating and Improving Physician Prescribing

  2002cites this paper